Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROGEN CORP | 224,000 | reported | 25 Jul 2008 | tx 5+882,650 |
| ACADIA PHARMACEUTICALS INC | 186,555 | reported | 19 Aug 2024 | tx 119+5,222,481−1,843,190 |
| BELLICUM PHARMACEUTICALS, INC | 136,854 | reported | 03 Jan 2023 | tx 14+267,736−18,715 |
| HERON THERAPEUTICS, INC. /DE/ | 77,160 | reported | 16 Dec 2022 | tx 22+12,562,995−254,035 |
| Furiex Pharmaceuticals, Inc. | 0 | reported | 02 Jul 2014 | tx 3+9,308−9,308 |
| TRIMERIS INC | 0 | reported | 22 Jun 2015 | tx 35+192,500−263,500 |
| INTRABIOTICS PHARMACEUTICALS INC /DE | 0 | reported | 19 Jun 2012 | tx 34+335,000−348,830 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Aug 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 44,782 | 0.00 USD | |
| 16 Aug 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 17,333 | 0.00 USD | |
| 19 Aug 2024 | SALE | ACADIA PHARMACEUTICALS INC | 31,747 | 15.28 USD | |
| 02 May 2024 | SALE | ACADIA PHARMACEUTICALS INC | 11,427 | 16.94 USD | |
| 01 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 22,391 | — | |
| 01 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 22,391 | 0.00 USD | deriv |
| 05 Apr 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 17,333 | — | |
| 08 Apr 2024 | SALE | ACADIA PHARMACEUTICALS INC | 17,716 | 17.87 USD | |
| 05 Apr 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 34,666 | — | |
| 08 Apr 2024 | SALE | ACADIA PHARMACEUTICALS INC | 8,858 | 17.87 USD | |
| 05 Apr 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 17,333 | 0.00 USD | deriv |
| 05 Apr 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 34,666 | 0.00 USD | deriv |
| 27 Mar 2024 | SALE | ACADIA PHARMACEUTICALS INC | 17,714 | 17.90 USD | |
| 25 Mar 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 34,666 | 0.00 USD | |
| 25 Mar 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 286,451 | 0.00 USD | deriv |
| 23 Feb 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 10,946 | — | |
| 26 Feb 2024 | SALE | ACADIA PHARMACEUTICALS INC | 5,577 | 24.67 USD | |
| 23 Feb 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 10,946 | 0.00 USD | deriv |
| 08 Jan 2024 | SALE | ACADIA PHARMACEUTICALS INC | 3,732 | 29.96 USD | |
| 06 Jan 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,528 | — | |
| 06 Jan 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,528 | 0.00 USD | deriv |
| 05 Oct 2023 | EXERCISE | ACADIA PHARMACEUTICALS INC | 103,999 | — | |
| 06 Oct 2023 | SALE | ACADIA PHARMACEUTICALS INC | 51,563 | 21.96 USD | |
| 06 Oct 2023 | EXERCISE | ACADIA PHARMACEUTICALS INC | 103,999 | 0.00 USD | deriv |
| 14 Jul 2023 | SALE | ACADIA PHARMACEUTICALS INC | 100,000 | 30.04 USD |